| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/15/2006 | US7091321 Enhancing the circulating half-life of antibody-based fusion proteins |
| 08/15/2006 | US7091315 heterologous polypeptide is the Fc domain of immunoglobulins, used to stimulate biosynthesis of interferons, or for diagnosis or prophylaxis of diseases; immunostimulants |
| 08/15/2006 | US7091176 Methods for treating arthritis pain |
| 08/15/2006 | US7091047 Methods and kits for diagnosing tumorigenicity |
| 08/15/2006 | US7091030 Composition for the preservation of viruses |
| 08/15/2006 | US7091022 Mitogen activated kinase |
| 08/15/2006 | US7090981 Chicken anaemia viruses of low pathogenicity |
| 08/15/2006 | US7090980 Method of detecting acid-fast bacteria using ribosomal RNA as target |
| 08/15/2006 | US7090864 Non-invasive gene targeting to ocular cells |
| 08/15/2006 | US7090857 Polysaccharides and/or glycopeptides preparable from keratinophilic fungi and yeasts; vaccines, immunomodulators, and antiallergens; precipitation and separation of supernatant; treatment with mineral or organic acid |
| 08/15/2006 | US7090856 Anti-fouling exopolysaccharides isolated from cultures of Vibrio alginolyticus and Vibrio proteolyticus |
| 08/15/2006 | US7090855 Prevention of Type 1 diabetes and other non-polio enterovirus diseases |
| 08/15/2006 | US7090854 Chicken anaemia viruses of low pathogenicity |
| 08/15/2006 | US7090853 Noscapine derivatives as adjuvant compositions and methods of use thereof |
| 08/15/2006 | US7090852 Virion protein; induce immunology response; genetic engineered Dna |
| 08/15/2006 | US7090851 Long lasting fusion peptide inhibitors of viral infection |
| 08/15/2006 | US7090850 Proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/15/2006 | US7090849 Babesia canis vaccine |
| 08/15/2006 | US7090848 immunology; genetic vaccines |
| 08/15/2006 | US7090845 Diagnosis and treatment of hepatic disorders |
| 08/15/2006 | US7090844 monoclonal antibody comprising a heavy chain amino acid; treatment of disorders associated with increased activity of MUC18, in particular, tumors, such as melanomas. |
| 08/15/2006 | US7090843 immunotherapy; fusion proteins; antitumor agents; for treatment and prevention of hodgkin's disease |
| 08/15/2006 | US7090842 antigen-binding fragment comprises immunoglobulin variable region light chains and heavy chains, produced by hybridoma; fusion proteins |
| 08/15/2006 | US7090841 comprises antibodies for decreasing human immunodeficiency virus entry into macrophage cells |
| 08/15/2006 | CA2155329C Acylfulvene analogues as antitumor agents |
| 08/10/2006 | WO2006084264A2 Cd20 antibody variants and uses thereof |
| 08/10/2006 | WO2006084226A2 Antibodies that bind to epha2 and methods of use thereof |
| 08/10/2006 | WO2006084129A2 Genes of porphyromonas gingivalis w83 involved in invasion of human cells |
| 08/10/2006 | WO2006084092A2 Antibodies to oncostatin m receptor |
| 08/10/2006 | WO2006084078A2 Jam-3 and antibodies that bind thereto |
| 08/10/2006 | WO2006084054A2 Method of treating angiogenic diseases |
| 08/10/2006 | WO2006084006A1 Human antibodies against rabies and uses thereof |
| 08/10/2006 | WO2006083984A1 Papillomavirus l2 n-terminal peptides for the induction of broadly cross-neutralizing antibodies |
| 08/10/2006 | WO2006083964A2 Modified fusion molecules for treatment of allergic disease |
| 08/10/2006 | WO2006083947A2 Compositions and methods for treating fibrotic disorders |
| 08/10/2006 | WO2006083937A2 Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists |
| 08/10/2006 | WO2006083936A2 Anti-ephb2 antibodies and methods using same |
| 08/10/2006 | WO2006083874A2 Vaccine delivery compositions and methods of use |
| 08/10/2006 | WO2006083681A2 Coated microprojections having reduced variability and method for producing same |
| 08/10/2006 | WO2006083671A2 Bacterial glycolipid activation of cd1d-restricted nkt cells |
| 08/10/2006 | WO2006083562A2 Method and multicomponent conjugates for treating cancer |
| 08/10/2006 | WO2006083322A2 Methods for the treatment and prevention of infection using anti-selectin agents |
| 08/10/2006 | WO2006083301A2 Immunogenic compositions comprising hmgb1 polypeptides |
| 08/10/2006 | WO2006083289A2 Methods and compositions for enhancement of immunity by in vivo depletion of immunosuppressive cell activity |
| 08/10/2006 | WO2006083288A1 Bacteriophages that infect bacillus bacteria (anthrax) |
| 08/10/2006 | WO2006083286A2 Genetically engineered swine influenza virus and uses thereof |
| 08/10/2006 | WO2006083257A2 Drug delivery apparatus utilizing cantilever |
| 08/10/2006 | WO2006083183A1 Use of myostatin (gdf-8) antagonists for treatment of sarcopenia (age-related muscle-wasting) |
| 08/10/2006 | WO2006083182A1 Use of myostatin (gdf-8) antagonists for improving wound healing and preventing fibrotic disease |
| 08/10/2006 | WO2006082974A1 Remedy for ischemic disease |
| 08/10/2006 | WO2006082530A2 Conjugation of streptococcal capsular saccharides to carrier proteins |
| 08/10/2006 | WO2006082406A2 Human antibodies and proteins |
| 08/10/2006 | WO2006082398A2 Nucleic acid constructs |
| 08/10/2006 | WO2006082328A2 Compositions comprising dehydrated micro-organisms, method for preparing same, and uses thereof |
| 08/10/2006 | WO2006082052A1 Synergistic combination of xolair/omalizumab/e25 with immunosuppressive agent |
| 08/10/2006 | WO2006081826A2 Survivin peptide vaccine |
| 08/10/2006 | WO2006081822A2 Minor allergen control to increase safety of immunotherapy |
| 08/10/2006 | WO2006081669A1 Anti-t cell and autoantigen treatment of autoimmune disease |
| 08/10/2006 | WO2006081631A1 Adjuvanting material |
| 08/10/2006 | WO2006066020A3 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 08/10/2006 | WO2006064378A3 Adjuvant activity of gastrointestinal peptides |
| 08/10/2006 | WO2006059069A3 Ion channel |
| 08/10/2006 | WO2006055331A3 Porcine reproductive and respiratory syndrome virus strains and compositions |
| 08/10/2006 | WO2006044857A3 Vaccines against japanese encephalitis virus and west nile virus |
| 08/10/2006 | WO2006039644A3 Methods of treating cd30 positive lymphomas |
| 08/10/2006 | WO2006036879A3 Chimeric gb virus b (gbv-b) |
| 08/10/2006 | WO2006036550A3 Listeria-based and llo-based vaccines |
| 08/10/2006 | WO2006034404A3 Treating neoplasms with neurotoxin |
| 08/10/2006 | WO2006033688A3 Anti-lympho- plus anti-monocytes globulin preparation for inhibiting immune responses |
| 08/10/2006 | WO2006029632A3 Chimeric phage-derived particles, methods for their production and use |
| 08/10/2006 | WO2006028634A3 Site specific pegylation of broadly-neutralizing antibodies against hepatitis c virus and their use in the treatment of chronic hcv infections |
| 08/10/2006 | WO2006027300A3 Carrier conjugates of gnrh-peptides |
| 08/10/2006 | WO2005122739A3 Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus |
| 08/10/2006 | WO2005120166A3 Antibodies for selective apoptosis of cells |
| 08/10/2006 | WO2005115455A3 Methods and reagents for the treatment of immunoinflammatory disorders |
| 08/10/2006 | WO2005110493A3 Methods for delivering mbd peptide-linked agent into cells under conditions of cellular stress |
| 08/10/2006 | WO2005110379A3 Pulmonary malarial vaccine |
| 08/10/2006 | WO2005101966B1 Lipid-extracted therapeutic vaccine and method of use |
| 08/10/2006 | WO2005092073A3 Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation |
| 08/10/2006 | WO2005086663A3 Polypeptides for inducing a protective immune response against staphlococcus aureus |
| 08/10/2006 | WO2005077048A3 Immune modulation by regulating expression of the “minor” gene in immune dendritic cells |
| 08/10/2006 | WO2004087886A3 Modified adenoviral e1a constructs and methods of use thereof |
| 08/10/2006 | WO2004060381A8 Rabbit skin comprising biological active substance and its use |
| 08/10/2006 | WO2003074004A3 Method of producing antigens |
| 08/10/2006 | WO2003065999A3 Proliferated cell lines and uses thereof |
| 08/10/2006 | US20060179496 Nucleic acid sequences differentially expressed in cancer tissue |
| 08/10/2006 | US20060179494 Non-human animal exhibiting bone metastasis of tumor cells |
| 08/10/2006 | US20060179493 Transgenically produced non-secreted proteins |
| 08/10/2006 | US20060178518 3'-[(2z)-[1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hy-drazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 08/10/2006 | US20060178504 Eotaxin: eosinophil chemotactic cytokine |
| 08/10/2006 | US20060178323 Methods for the treatment of chronic pain and compositions therefor |
| 08/10/2006 | US20060177909 Preparation of immunoglobulin |
| 08/10/2006 | US20060177866 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
| 08/10/2006 | US20060177861 Novel compositions and methods in cancer associated with altered expression of MCM3AP |
| 08/10/2006 | US20060177854 Hereditary hemochromatosis gene |
| 08/10/2006 | US20060177470 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 08/10/2006 | US20060177469 Non-toxic mucosal adjuvant |
| 08/10/2006 | US20060177468 Delivery vehicles, bioactive substances and viral vaccines |
| 08/10/2006 | US20060177466 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/10/2006 | US20060177465 Polypeptide antigens of streptococcus pneumoniae pathogen useful as vaccine for prophylaxis, diagnostic or treatment of streptococcal infection |